12h
Pharmaceutical Technology on MSNNeurona raises $102m to advance cell therapy for drug-resistant epilepsyNeurona will kick start a Phase III trial in H2 2025 investigating NRTX-1001 in patients with a type of drug-resistant ...
That’s not unusual. A 2007 study published in The Journal of Neuroscience found that professional musicians tend to develop a ...
1d
PsyPost on MSNCognitive flexibility test reveals subtle signs of Alzheimer’s in healthy older adultsNew research published in Alzheimer’s Research & Therapy suggests that small shifts in how the brain processes information ...
Neurona Therapeutics has circled up $102 million to push its off-the-shelf cell therapy for epilepsy through phase 3 testing.
A novel study has shed new light on the brain structures critical to human verbal memory, offering valuable insights for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results